{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:57:08Z","timestamp":1792515428918,"version":"4.5.0"},"reference-count":255,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.autrev.2017.12.001","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T00:38:21Z","timestamp":1517359101000},"page":"201-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Cardiovascular involvement in systemic rheumatic diseases: An integrated view for the treating physicians"],"prefix":"10.1016","volume":"17","author":[{"given":"Kwang Seob","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kronbichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Eisenhut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keum Hwa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Il","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2017.12.001_bb0005","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1177\/0961203315593169","article-title":"Colchicine: a simple and effective treatment for pericarditis in systemic lupus erythematosus? A report of 10 cases","volume":"24","author":"Morel","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.12.001_bb0010","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-215423","article-title":"Successful treatment of recurrent pleural and pericardial effusions with tocilizumab in a patient with systemic lupus erythematous","volume":"2016","author":"Ocampo","year":"2016","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.autrev.2017.12.001_bb0015","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1177\/0961203308100659","article-title":"The spectrum of clinical manifestations, outcome and treatment of pericardial tamponade in patients with systemic lupus erythematosus: a retrospective study and literature review","volume":"18","author":"Rosenbaum","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.12.001_bb0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijcard.2014.11.191","article-title":"Pericardial effusions in systemic lupus erythematosus - who is most likely to develop tamponade?","volume":"180","author":"Maharaj","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0025","first-page":"273","article-title":"Systemic lupus erythematosus initially manifesting as acute pericarditis complicating with cardiac tamponade: a case report","volume":"49","author":"Shimizu","year":"2007","journal-title":"J Cardiol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0030","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.autrev.2016.09.007","article-title":"Prevalence and predictors of valvular heart disease in patients with systemic lupus erythematosus","volume":"15","author":"Vivero","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.12.001_bb0035","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/eci.12744","article-title":"The association between SLE and valvular heart disease: an extensive data analysis","volume":"47","author":"Watad","year":"2017","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.autrev.2017.12.001_bb0040","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.amjmed.2007.01.024","article-title":"Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution","volume":"120","author":"Moyssakis","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2017.12.001_bb0045","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1161\/CIRCULATIONAHA.106.678334","article-title":"Cardiovascular manifestations of rheumatologic diseases","volume":"116","author":"Roman","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2017.12.001_bb0050","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/CIRCULATIONAHA.111.028522","article-title":"Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies","volume":"124","author":"Zuily","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2017.12.001_bb0055","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/14397595.2016.1208136","article-title":"Anti-Ro\/SSA antibodies are associated with severe mitral valve regurgitation in patients with systemic lupus erythematosus","volume":"27","author":"Higuera-Ortiz","year":"2017","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0060","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/art.21162","article-title":"Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, followup study","volume":"53","author":"Perez-Villa","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.12.001_bb0065","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/01.hdx.0000089834.97829.5e","article-title":"Valvular heart disease and systemic lupus erythematosus: therapeutic implications","volume":"5","author":"Fluture","year":"2003","journal-title":"Heart Dis"},{"key":"10.1016\/j.autrev.2017.12.001_bb0070","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa035611","article-title":"Premature coronary-artery atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Asanuma","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2017.12.001_bb0075","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMoa035471","article-title":"Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Roman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2017.12.001_bb0080","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.autrev.2015.10.002","article-title":"Subclinical atherosclerosis in patients with systemic lupus erythematosus: a systemic review and meta-analysis","volume":"15","author":"Wu","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.12.001_bb0085","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.autrev.2017.01.009","article-title":"Subclinical atherosclerosis in systemic lupus erythematosus: comparable risk with diabetes mellitus and rheumatoid arthritis","volume":"16","author":"Tektonidou","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.12.001_bb0090","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/annrheumdis-2012-201940","article-title":"Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis","volume":"71","author":"Bertsias","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.12.001_bb0095","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/FJC.0b013e31829dd857","article-title":"Atherosclerosis in systemic lupus erythematosus","volume":"62","author":"Stojan","year":"2013","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0100","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.ijcard.2014.08.006","article-title":"Increased risk of acute myocardial infarction and mortality in patients with systemic lupus erythematosus: two nationwide retrospective cohort studies","volume":"176","author":"Lin","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0105","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/aje\/kws130","article-title":"Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus","volume":"176","author":"Magder","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0110","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","article-title":"Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study","volume":"145","author":"Manzi","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/CIRCINTERVENTIONS.108.788745","article-title":"Poor 1-year outcomes after percutaneous coronary interventions in systemic lupus erythematosus: report from the National Heart, Lung, and Blood Institute Dynamic Registry","volume":"1","author":"Maksimowicz-McKinnon","year":"2008","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.autrev.2017.12.001_bb0120","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3899\/jrheum.150460","article-title":"Optimal monitoring for coronary heart disease risk in patients with systemic lupus erythematosus: a systematic review","volume":"43","author":"Tselios","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0125","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/0002-8703(87)90058-5","article-title":"Alterations in myocardial systolic and diastolic function in patients with active systemic lupus erythematosus","volume":"113","author":"Murai","year":"1987","journal-title":"Am Heart J"},{"key":"10.1016\/j.autrev.2017.12.001_bb0130","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0002-8703(90)90163-R","article-title":"Doppler echocardiographic evaluation of left ventricular diastolic function in patients with systemic lupus erythematosus","volume":"120","author":"Leung","year":"1990","journal-title":"Am Heart J"},{"key":"10.1016\/j.autrev.2017.12.001_bb0135","first-page":"243","article-title":"Myocardial involvement in systemic lupus erythematosus and systemic sclerosis\u2013pulsed Doppler echocardiographic evaluation of left ventricular diastolic function","volume":"30","author":"Stanescu","year":"1992","journal-title":"Rom J Intern Med"},{"issue":"6","key":"10.1016\/j.autrev.2017.12.001_bb0140","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2143\/AC.56.6.2005702","article-title":"Evaluation of myocardial involvement in systemic lupus erythematosus by signal-averaged electrocardiography and echocardiography","volume":"56","author":"Paradiso","year":"2001","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0145","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1177\/0961203308089401","article-title":"Myocardial tissue characterization in systemic lupus erythematosus: value of a comprehensive cardiovascular magnetic resonance approach","volume":"17","author":"Abdel-Aty","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.12.001_bb0150","doi-asserted-by":"crossref","first-page":"47","DOI":"10.11152\/mu.2013.2066.181.zdr","article-title":"Subclinical myocardial impairment in SLE: insights from novel ultrasound techniques and clinical determinants","volume":"18","author":"Gusetu","year":"2016","journal-title":"Med Ultrason"},{"key":"10.1016\/j.autrev.2017.12.001_bb0155","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s10067-017-3582-0","article-title":"Prevalence of resting-ECG abnormalities in systemic lupus erythematosus: a single-center experience","volume":"36","author":"Myung","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0160","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.autrev.2010.05.018","article-title":"Endothelial dysfunction and vascular stiffness in systemic lupus erythematosus: are they early markers of subclinical atherosclerosis?","volume":"9","author":"Zardi","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.12.001_bb0165","first-page":"295","article-title":"Endothelial function and arterial stiffness assessment as early surrogate markers of vascular risk in patients with systemic lupus erythematosus","volume":"31","author":"Chin","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094511","article-title":"Increased arterial stiffness in systemic lupus erythematosus (SLE) patients at low risk for cardiovascular disease: a cross-sectional controlled study","volume":"9","author":"Sacre","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.autrev.2017.12.001_bb0175","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/acr.20470","article-title":"Prolonged corrected QT interval in anti-Ro\/SSA-positive adults with systemic lupus erythematosus","volume":"63","author":"Bourre-Tessier","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2017.12.001_bb0180","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00296-013-2718-z","article-title":"Prolongation of heart rate-corrected QT interval is a predictor of cardiac autonomic dysfunction in patients with systemic lupus erythematosus","volume":"34","author":"Nomura","year":"2014","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2017.12.001_bb0185","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/europace\/eut290","article-title":"Evidence for cardiac safety and antiarrhythmic potential of chloroquine in systemic lupus erythematosus","volume":"16","author":"Teixeira","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.autrev.2017.12.001_bb0190","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000110485","article-title":"Asymptomatic pericardial effusion in patients with rheumatoid arthritis","volume":"110","author":"Sugiura","year":"2008","journal-title":"Cardiology"},{"key":"10.1016\/j.autrev.2017.12.001_bb0195","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.ijcard.2012.05.057","article-title":"Heart involvement in rheumatoid arthritis: systematic review and meta-analysis","volume":"167","author":"Corrao","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0200","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/1529-0131(200104)45:2<129::AID-ANR164>3.0.CO;2-K","article-title":"Cardiac manifestations of rheumatoid arthritis: a case-control transesophageal echocardiography study in 30 patients","volume":"45","author":"Guedes","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.12.001_bb0205","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7861\/clinmedicine.1-1-18","article-title":"Cardiac involvement in rheumatoid disease","volume":"1","author":"Kitas","year":"2001","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.autrev.2017.12.001_bb0210","first-page":"112","article-title":"Aortic insufficiency and rheumatoid nodules - a rare occurrence","volume":"35","author":"Abreu","year":"2010","journal-title":"Acta Reumatol Port"},{"key":"10.1016\/j.autrev.2017.12.001_bb0215","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.acvd.2008.10.018","article-title":"Fast progression of aortic stenosis in rheumatoid arthritis","volume":"102","author":"Peyrou","year":"2009","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.autrev.2017.12.001_bb0220","first-page":"267","article-title":"A case of acute aortic insufficiency due to severe rheumatoid arthritis, showing progression in two weeks","volume":"4","author":"Shingaki","year":"2014","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.autrev.2017.12.001_bb0225","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.5830\/CVJA-2012-012","article-title":"Severe cardiac failure due to rapidly progressive rheumatoid arthritis-associated valvulopathy","volume":"23","author":"Tarkin","year":"2012","journal-title":"Cardiovasc J Afr"},{"key":"10.1016\/j.autrev.2017.12.001_bb0230","first-page":"52","article-title":"Valvular involvement in patients with rheumatoid arthritis","volume":"34","author":"Beckhauser","year":"2009","journal-title":"Acta Reumatol Port"},{"key":"10.1016\/j.autrev.2017.12.001_bb0235","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.amjcard.2007.03.048","article-title":"Characterization of valvular heart disease in rheumatoid arthritis by transesophageal echocardiography and clinical correlates","volume":"100","author":"Roldan","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0240","first-page":"14","article-title":"Mitral valve procedure selection and outcomes in patients with rheumatoid arthritis","volume":"22","author":"Vassileva","year":"2013","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.autrev.2017.12.001_bb0245","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/acr.22642","article-title":"Cause-specific mortality in male US veterans with rheumatoid arthritis","volume":"68","author":"England","year":"2016","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2017.12.001_bb0250","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3109\/03009741003604542","article-title":"Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA","volume":"39","author":"Nakajima","year":"2010","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0255","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/acr.22752","article-title":"Rheumatoid arthritis and mortality among women during 36\u202fyears of prospective follow-up: results from the nurses' health study","volume":"68","author":"Sparks","year":"2016","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2017.12.001_bb0260","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/art.30265","article-title":"Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis","volume":"63","author":"Evans","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.12.001_bb0265","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.autrev.2016.01.006","article-title":"Coexistence of ischemic heart disease and rheumatoid arthritis patients-a case control study","volume":"15","author":"Houri Levi","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.12.001_bb0270","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/art.20853","article-title":"Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.12.001_bb0275","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1160\/TH14-11-0921","article-title":"Subclinical atherosclerosis in patients with rheumatoid arthritis. A meta-analysis of literature studies","volume":"113","author":"Ambrosino","year":"2015","journal-title":"Thromb Haemost"},{"issue":"827","key":"10.1016\/j.autrev.2017.12.001_bb0280","article-title":"Imaging atherosclerosis in rheumatoid arthritis: evidence for increased prevalence, altered phenotype and a link between systemic and localised plaque inflammation","volume":"7","author":"Skeoch","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2017.12.001_bb0285","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s10067-015-2996-9","article-title":"Prevalence of atherosclerosis in patients with inactive rheumatoid arthritis","volume":"34","author":"Dehghan","year":"2015","journal-title":"Clin Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2017.12.001_bb0290","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1136\/ard.2005.050377","article-title":"Patterns of cardiovascular risk in rheumatoid arthritis","volume":"65","author":"Solomon","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.12.001_bb0295","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ahj.2013.07.010","article-title":"Rheumatoid arthritis and cardiovascular disease","volume":"166","author":"Crowson","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.autrev.2017.12.001_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117952","article-title":"The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"10","author":"Baghdadi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2017.12.001_bb0305","first-page":"1078","article-title":"Prevalence of atherosclerosis in diabetic and non-diabetic patients with rheumatoid arthritis","volume":"31","author":"Kisiel","year":"2015","journal-title":"Pak J Med Sci"},{"key":"10.1016\/j.autrev.2017.12.001_bb0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170108","article-title":"Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1\u202fyear prospective single centre study","volume":"12","author":"Ruscitti","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2017.12.001_bb0315","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.3899\/jrheum.160053","article-title":"Predictive value of arterial stiffness and subclinical carotid atherosclerosis for cardiovascular disease in patients with rheumatoid arthritis","volume":"43","author":"Ikdahl","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0320","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2008.06.010","article-title":"Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus","volume":"121","author":"Salmon","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2017.12.001_bb0325","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.ejim.2015.10.016","article-title":"Clinical assessment of endothelial function in patients with rheumatoid arthritis: a meta-analysis of literature studies","volume":"26","author":"Di Minno","year":"2015","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.autrev.2017.12.001_bb0330","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.autrev.2016.07.026","article-title":"Cardiovascular risk assessment in patients with rheumatoid arthritis: the relevance of clinical, genetic and serological markers","volume":"15","author":"Lopez-Mejias","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.12.001_bb0335","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/acr.22930","article-title":"Association of rheumatoid factors with subclinical and clinical atherosclerosis in African American women: the multiethnic study of atherosclerosis","volume":"69","author":"Majka","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2017.12.001_bb0340","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1136\/ard.2009.110536","article-title":"Effect of rheumatoid factor on mortality and coronary heart disease","volume":"69","author":"Tomasson","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.12.001_bb0345","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1093\/eurheartj\/ehv461","article-title":"Rheumatoid arthritis is associated with a more severe presentation of acute coronary syndrome and worse short-term outcome","volume":"36","author":"Mantel","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.autrev.2017.12.001_bb0350","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1136\/ard.2009.124362","article-title":"Increased prevalence of diastolic dysfunction in rheumatoid arthritis","volume":"69","author":"Liang","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.12.001_bb0355","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s10067-002-0677-y","article-title":"Doppler echocardiographic evaluation of ventricular function in patients with rheumatoid arthritis","volume":"22","author":"Alpaslan","year":"2003","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0360","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s10067-005-0014-3","article-title":"Diastolic function abnormalities in active rheumatoid arthritis evaluation by conventional Doppler and tissue Doppler: relation with duration of disease","volume":"25","author":"Arslan","year":"2006","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0365","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/art.27349","article-title":"Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging","volume":"62","author":"Giles","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.12.001_bb0370","first-page":"416","article-title":"Cardiac magnetic resonance imaging reveals frequent myocardial involvement and dysfunction in active rheumatoid arthritis","volume":"34","author":"Holmstrom","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0375","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00296-003-0342-z","article-title":"Ventricular function abnormalities in active rheumatoid arthritis: a Doppler echocardiographic study","volume":"24","author":"Levendoglu","year":"2004","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2017.12.001_bb0380","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1368-5031.2006.00746.x","article-title":"Left and right ventricular diastolic functions in patients with rheumatoid arthritis without clinically evident cardiovascular disease","volume":"60","author":"Rexhepaj","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.autrev.2017.12.001_bb0385","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s10554-006-9096-5","article-title":"Right ventricular diastolic abnormalities in rheumatoid arthritis and its relationship with left ventricular and pulmonary involvement. A tissue Doppler echocardiographic study","volume":"22","author":"Seyfeli","year":"2006","journal-title":"Int J Cardiovasc Imaging"},{"issue":"8","key":"10.1016\/j.autrev.2017.12.001_bb0390","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.2310\/JIM.0b013e3182746a83","article-title":"Echocardiographic evaluation of asymptomatic patients affected by rheumatoid arthritis","volume":"60","author":"Vizzardi","year":"2012","journal-title":"J Investig Med"},{"key":"10.1016\/j.autrev.2017.12.001_bb0395","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3899\/jrheum.100979","article-title":"The influence of rheumatoid arthritis disease characteristics on heart failure","volume":"38","author":"Myasoedova","year":"2011","journal-title":"J Rheumatol"},{"issue":"809514","key":"10.1016\/j.autrev.2017.12.001_bb0400","article-title":"Increased incidence of atrial fibrillation in patients with rheumatoid arthritis","volume":"2015","author":"Bacani","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.autrev.2017.12.001_bb0405","first-page":"1717","article-title":"Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis","volume":"38","author":"Lazzerini","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.autrev.2017.12.001_bb0410","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/j.hrthm.2011.06.036","article-title":"Ischemic ventricular arrhythmias: experimental models and their clinical relevance","volume":"8","author":"Di Diego","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.autrev.2017.12.001_bb0415","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/01.RES.0000145047.14691.db","article-title":"What causes sudden death in heart failure?","volume":"95","author":"Tomaselli","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.autrev.2017.12.001_bb0420","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3899\/jrheum.140861","article-title":"Association between corrected QT interval and inflammatory cytokines in rheumatoid arthritis","volume":"42","author":"Adlan","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0425","first-page":"84","article-title":"Population-based study of QT interval prolongation in patients with rheumatoid arthritis","volume":"33","author":"Chauhan","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0430","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/030097402317255327","article-title":"QT dispersion and cardiac involvement in patients with rheumatoid arthritis","volume":"31","author":"Cindas","year":"2002","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0435","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1136\/heartjnl-2016-311079","article-title":"Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes","volume":"103","author":"Lazzerini","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.autrev.2017.12.001_bb0440","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/rheumatology\/ket338","article-title":"Prolonged QTc interval predicts all-cause mortality in patients with rheumatoid arthritis: an association driven by high inflammatory burden","volume":"53","author":"Panoulas","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2017.12.001_bb0445","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1056\/NEJMra000650","article-title":"Sudden death due to cardiac arrhythmias","volume":"345","author":"Huikuri","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2017.12.001_bb0450","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/acr.22455","article-title":"Antiarrhythmic potential of anticytokine therapy in rheumatoid arthritis: tocilizumab reduces corrected QT interval by controlling systemic inflammation","volume":"67","author":"Lazzerini","year":"2015","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2017.12.001_bb0455","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.semarthrit.2014.06.003","article-title":"Autonomic function and rheumatoid arthritis: a systematic review","volume":"44","author":"Adlan","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.12.001_bb0460","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e1257","article-title":"Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study","volume":"344","author":"Lindhardsen","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.autrev.2017.12.001_bb0465","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s12026-016-8833-7","article-title":"Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad","volume":"65","author":"Lazzerini","year":"2017","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2017.12.001_bb0470","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3899\/jrheum.110158","article-title":"Biological drug treatment of rheumatoid arthritis and spondyloarthritis: effects on QT interval and QT dispersion","volume":"39","author":"DIF","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0475","first-page":"85","article-title":"Interleukin-6 blockade improves autonomic dysfunction in rheumatoid arthritis","volume":"40","author":"Syngle","year":"2015","journal-title":"Acta Reumatol Port"},{"key":"10.1016\/j.autrev.2017.12.001_bb0480","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"74","author":"Roubille","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.12.001_bb0485","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.3899\/jrheum.121380","article-title":"The 15% rule in scleroderma: the frequency of severe organ complications in systemic sclerosis. A systematic review","volume":"40","author":"Muangchan","year":"2013","journal-title":"J Rheumatol"},{"issue":"Suppl. 3","key":"10.1016\/j.autrev.2017.12.001_bb0490","first-page":"iii45","article-title":"Cardiac complications of systemic sclerosis","volume":"48","author":"Kahan","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2017.12.001_bb0495","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/1756-185X.12952","article-title":"Cardiac tamponade and severe pericardial effusion in systemic sclerosis: report of nine patients and review of the literature","volume":"20","author":"Fernandez Morales","year":"2016","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2017.12.001_bb0500","doi-asserted-by":"crossref","first-page":"314","DOI":"10.12932\/AP0305.31.4.2013","article-title":"Pericardial fluid profiles of pericardial effusion in systemic sclerosis patients","volume":"31","author":"Kitchongcharoenying","year":"2013","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0505","doi-asserted-by":"crossref","first-page":"993","DOI":"10.4330\/wjc.v6.i9.993","article-title":"Cardiac manifestations in systemic sclerosis","volume":"6","author":"Lambova","year":"2014","journal-title":"World J Cardiol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0510","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.rdc.2007.12.002","article-title":"The heart in scleroderma","volume":"34","author":"Champion","year":"2008","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.autrev.2017.12.001_bb0515","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/art.30380","article-title":"Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis","volume":"63","author":"Au","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.12.001_bb0520","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/1756-185X.12566","article-title":"A qualitative systematic review of the prevalence of coronary artery disease in systemic sclerosis","volume":"18","author":"Ali","year":"2015","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2017.12.001_bb0525","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.amjmed.2013.06.025","article-title":"Increased risk of acute myocardial infarction in systemic sclerosis: a nationwide population-based study","volume":"126","author":"Chu","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2017.12.001_bb0530","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/rheumatology\/keh087","article-title":"Blunted coronary flow reserve in systemic sclerosis","volume":"43","author":"Sulli","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2017.12.001_bb0535","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/rheumatology\/keu350","article-title":"Assessment of myocardial fibrosis and microvascular damage in systemic sclerosis by magnetic resonance imaging and coronary angiotomography","volume":"54","author":"Rodriguez-Reyna","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl. 4","key":"10.1016\/j.autrev.2017.12.001_bb0540","doi-asserted-by":"crossref","first-page":"iv14","DOI":"10.1093\/rheumatology\/kel312","article-title":"Primary myocardial involvement in systemic sclerosis","volume":"45","author":"Kahan","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2017.12.001_bb0545","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1532-429X-16-21","article-title":"Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis\u2013a clinical study using myocardial T1-mapping and extracellular volume quantification","volume":"16","author":"Ntusi","year":"2014","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.autrev.2017.12.001_bb0550","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s11547-014-0430-z","article-title":"Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance","volume":"119","author":"Moroncini","year":"2014","journal-title":"Radiol Med"},{"key":"10.1016\/j.autrev.2017.12.001_bb0555","first-page":"S48","article-title":"Primary myocardial involvement in systemic sclerosis: evidence for a microvascular origin","volume":"28","author":"Allanore","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0560","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1016\/j.ijcard.2011.12.039","article-title":"Myocardial perfusion-fibrosis pattern in systemic sclerosis assessed by cardiac magnetic resonance","volume":"159","author":"Mavrogeni","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0565","first-page":"135","article-title":"Cold-induced coronary Raynaud's phenomenon in patients with systemic sclerosis","volume":"16","author":"Lekakis","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0570","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0002-8703(93)90075-K","article-title":"Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association","volume":"125","author":"Follansbee","year":"1993","journal-title":"Am Heart J"},{"key":"10.1016\/j.autrev.2017.12.001_bb0575","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3109\/03009741003774626","article-title":"Myopathies related to systemic sclerosis: a case-control study of associated clinical and immunological features","volume":"39","author":"Ranque","year":"2010","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0580","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/clpt.1990.61","article-title":"The effect of captopril on thallium 201 myocardial perfusion in systemic sclerosis","volume":"47","author":"Kahan","year":"1990","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.autrev.2017.12.001_bb0585","first-page":"1395","article-title":"Nicardipine improves myocardial perfusion in systemic sclerosis","volume":"15","author":"Kahan","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0590","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2174\/13816128113199990555","article-title":"Micro- and macrovascular treatment targets in scleroderma heart disease","volume":"20","author":"Dimitroulas","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.autrev.2017.12.001_bb0595","first-page":"431","article-title":"Glucocorticoid effects on myocardial performance in patients with systemic sclerosis","volume":"19","author":"Antoniades","year":"2001","journal-title":"Clin Exp Rheumatol"},{"issue":"95","key":"10.1016\/j.autrev.2017.12.001_bb0600","article-title":"Renal involvement in autoimmune connective tissue diseases","volume":"11","author":"Kronbichler","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.autrev.2017.12.001_bb0605","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.autrev.2017.12.001_bb0610","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/rheumatology\/ket377","article-title":"Cardiac arrhythmias and conduction defects in systemic sclerosis","volume":"53","author":"Vacca","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2017.12.001_bb0615","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0167-5273(96)02808-2","article-title":"Relationships between electrocardiographic and echocardiographic findings in systemic sclerosis (scleroderma)","volume":"57","author":"Morelli","year":"1996","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0620","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1542-474X.2009.00306.x","article-title":"Electrocardiographic evaluation in patients with systemic scleroderma and without clinically evident heart disease","volume":"14","author":"Bielous-Wilk","year":"2009","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0625","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0002-9343(81)90256-4","article-title":"The relationship arrhythmias and conduction disturbances to other manifestations of cardiopulmonary disease in progressive systemic sclerosis (PSS)","volume":"71","author":"Clements","year":"1981","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2017.12.001_bb0630","doi-asserted-by":"crossref","first-page":"38","DOI":"10.7326\/0003-4819-94-1-38","article-title":"The prevalence of conduction defects and cardiac arrhythmias in progressive systemic sclerosis","volume":"94","author":"Roberts","year":"1981","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2017.12.001_bb0635","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078808","article-title":"Right bundle branch block: a predictor of mortality in early systemic sclerosis","volume":"8","author":"Draeger","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2017.12.001_bb0640","first-page":"26","article-title":"Cardiovascular profiles of scleroderma patients with arrhythmias and conduction disorders","volume":"41","author":"Muresan","year":"2016","journal-title":"Acta Reumatol Port"},{"key":"10.1016\/j.autrev.2017.12.001_bb0645","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijcard.2014.12.069","article-title":"QTc interval prolongation in systemic sclerosis: correlations with clinical variables","volume":"182","author":"Rosato","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0650","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijcard.2017.03.088","article-title":"QTc interval prolongation in systemic sclerosis: correlations with clinical variables and arrhythmic risk","volume":"239","author":"De Luca","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0655","first-page":"920","article-title":"Heart rate turbulence impairment and ventricular arrhythmias in patients with systemic sclerosis","volume":"33","author":"Bienias","year":"2010","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0660","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/rheumatology\/kep394","article-title":"Heart rate turbulence assessment in systemic sclerosis: the role for the detection of cardiac autonomic nervous system dysfunction","volume":"49","author":"Bienias","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2017.12.001_bb0665","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/rheumatology\/36.6.669","article-title":"Autonomic dysfunction in systemic sclerosis: time and frequency domain 24\u202fhour heart rate variability analysis","volume":"36","author":"Ferri","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0670","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill consensus conference nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.12.001_bb0675","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1136\/annrheumdis-2013-204572","article-title":"Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case-control study","volume":"73","author":"Prieto-Gonzalez","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.12.001_bb0680","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/art.21699","article-title":"Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients","volume":"55","author":"Blockmans","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.12.001_bb0685","first-page":"502","article-title":"Ischemic heart disease in patients from Northwest Spain with biopsy proven giant cell arteritis. A population based study","volume":"32","author":"Gonzalez-Gay","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0690","first-page":"737","article-title":"Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden","volume":"29","author":"Uddhammar","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0695","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.3899\/jrheum.151500","article-title":"Predictors of cardiovascular hospitalization in giant cell arteritis: effect of statin exposure. A French population-based study","volume":"43","author":"Pugnet","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0700","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/01.crd.0000218853.05856.b6","article-title":"Giant cell arteritis: diagnosis, management, and cardiovascular implications","volume":"15","author":"Eberhardt","year":"2007","journal-title":"Cardiol Rev"},{"issue":"7","key":"10.1016\/j.autrev.2017.12.001_bb0705","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7326\/0003-4819-122-7-199504010-00004","article-title":"Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study","volume":"122","author":"Evans","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2017.12.001_bb0710","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1136\/annrheumdis-2012-202408","article-title":"Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis","volume":"72","author":"Kermani","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.12.001_bb0715","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1002\/art.11353","article-title":"Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and\/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50\u202fyears","volume":"48","author":"Nuenninghoff","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.12.001_bb0720","doi-asserted-by":"crossref","first-page":"484","DOI":"10.12998\/wjcc.v3.i6.484","article-title":"Giant cell arteritis: current treatment and management","volume":"3","author":"Ponte","year":"2015","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.autrev.2017.12.001_bb0725","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1148\/radiol.13122195","article-title":"Takayasu arteritis: assessment of coronary arterial abnormalities with 128-section dual-source CT angiography of the coronary arteries and aorta","volume":"270","author":"Kang","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.autrev.2017.12.001_bb0730","article-title":"Cause of death in Chinese Takayasu arteritis patients","volume":"95","author":"Li","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2017.12.001_bb0735","first-page":"65","article-title":"Cardiac lesions in non-specific aorto-arteritis. An autopsy study","volume":"46","author":"Kinare","year":"1994","journal-title":"Indian Heart J"},{"key":"10.1016\/j.autrev.2017.12.001_bb0740","first-page":"2138","article-title":"Clinical data analysis of valvular involvement in Takayasu arteritis","volume":"96","author":"Gao","year":"2016","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.autrev.2017.12.001_bb0745","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijcard.2011.01.094","article-title":"Cardiovascular manifestations of Takayasu arteritis and their relationship to the disease activity: analysis of 204 Korean patients at a single center","volume":"159","author":"Lee","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0750","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.amjcard.2013.11.045","article-title":"Findings of cardiac magnetic resonance imaging in asymptomatic myocardial ischemic disease in Takayasu arteritis","volume":"113","author":"Comarmond","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0755","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijcard.2017.02.041","article-title":"Outcomes of percutaneous coronary intervention and coronary artery bypass grafting in patients with Takayasu arteritis","volume":"241","author":"Yang","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0760","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s10067-015-2873-6","article-title":"High-sensitivity C-reactive protein predicts adverse cardiovascular events in patients with Takayasu arteritis with coronary artery involvement","volume":"35","author":"Wang","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0765","first-page":"297","article-title":"Clinical characteristics and long-term outcome of patients with acute coronary syndromes and Takayasu arteritis","volume":"32","author":"Soeiro Ade","year":"2013","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0770","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.semarthrit.2017.03.009","article-title":"Long-term outcomes of coronary artery bypass grafting versus percutaneous coronary intervention for Takayasu arteritis patients with coronary artery involvement","volume":"47","author":"Wang","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.12.001_bb0775","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0167-5273(93)90007-4","article-title":"Ventricular arrhythmias in Takayasu arteritis","volume":"40","author":"Siburian","year":"1993","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0780","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1177\/000331970005100907","article-title":"QT dispersion in patients with Takayasu arteritis","volume":"51","author":"Kato","year":"2000","journal-title":"Angiology"},{"key":"10.1016\/j.autrev.2017.12.001_bb0785","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.jcmg.2011.04.021","article-title":"CMR evaluation of cardiac involvement during the convalescence of Kawasaki disease","volume":"4","author":"Mavrogeni","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.autrev.2017.12.001_bb0790","first-page":"S140","article-title":"Acute cardiac valvular involvement in Kawasaki disease","volume":"29","author":"Pellegrin","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0795","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00431-012-1891-5","article-title":"Incomplete clinical manifestation as a risk factor for coronary artery abnormalities in Kawasaki disease: a meta-analysis","volume":"172","author":"Ha","year":"2013","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.autrev.2017.12.001_bb0800","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/archpedi.160.7.686","article-title":"Prevalence of coronary artery lesions on the initial echocardiogram in Kawasaki syndrome","volume":"160","author":"Baer","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.autrev.2017.12.001_bb0805","doi-asserted-by":"crossref","first-page":"75","DOI":"10.5603\/KP.a2015.0136","article-title":"Cardiac complications in children with Kawasaki disease in our own experience","volume":"74","author":"Gowin","year":"2016","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0810","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0002-8703(90)90081-8","article-title":"Valvular heart disease in Kawasaki syndrome: incidence and natural history","volume":"120","author":"Akagi","year":"1990","journal-title":"Am Heart J"},{"key":"10.1016\/j.autrev.2017.12.001_bb0815","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s11596-011-0587-9","article-title":"A meta-analysis of the biomarkers associated with coronary artery lesions secondary to Kawasaki disease in Chinese children","volume":"31","author":"Chen","year":"2011","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"10.1016\/j.autrev.2017.12.001_bb0820","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s12519-016-0023-0","article-title":"Meta-analysis of risk factors associated with atherosclerosis in patients with Kawasaki disease","volume":"12","author":"Zhang","year":"2016","journal-title":"World J Pediatr"},{"key":"10.1016\/j.autrev.2017.12.001_bb0825","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1542\/peds.2013-1638","article-title":"Long-term cardiovascular outcomes in survivors of Kawasaki disease","volume":"133","author":"Holve","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.autrev.2017.12.001_bb0830","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/archdischild-2014-306427","article-title":"Acute and late coronary outcomes in 1073 patients with Kawasaki disease with and without intravenous gamma-immunoglobulin therapy","volume":"100","author":"Lin","year":"2015","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.autrev.2017.12.001_bb0835","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/jamapediatrics.2016.2055","article-title":"Coronary artery complication in Kawasaki disease and the importance of early intervention: A systematic review and meta-analysis","volume":"170","author":"Chen","year":"2016","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.autrev.2017.12.001_bb0840","first-page":"233","article-title":"Corticosteroid therapy for primary treatment of Kawasaki disease - weight of evidence: a meta-analysis and systematic review of the literature","volume":"20","author":"Athappan","year":"2009","journal-title":"Cardiovasc J Afr"},{"key":"10.1016\/j.autrev.2017.12.001_bb0845","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.5603\/KP.a2013.0180","article-title":"Analysis of risk factors and prospective evaluation of cardiovascular complications of Kawasaki disease in children: a single centre study","volume":"71","author":"Berdej-Szczot","year":"2013","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0850","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijcard.2016.08.298","article-title":"Cardiac involvement in patients with rheumatic disorders: data of the RHEU-M(A)R study","volume":"224","author":"Greulich","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0855","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijcard.2015.06.087","article-title":"Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis","volume":"199","author":"Hazebroek","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0860","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/ard.2010.137778","article-title":"Long-term patient survival in ANCA-associated vasculitis","volume":"70","author":"Flossmann","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.12.001_bb0865","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.3899\/jrheum.131426","article-title":"Predictors for mortality in patients with antineutrophil cytoplasmic autoantibody-associated vasculitis: a study of 398 Chinese patients","volume":"41","author":"Lai","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0870","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.autrev.2010.07.009","article-title":"Microscopic polyangiitis: clinical presentation","volume":"9","author":"Villiger","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.12.001_bb0875","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.5603\/KP.a2016.0138","article-title":"Cardiac manifestations in antineutrophil cytoplasmic autoantibody (ANCA) - associated vasculitides","volume":"74","author":"Zycinska","year":"2016","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0880","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/art.37721","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis study group cohort","volume":"65","author":"Comarmond","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.12.001_bb0885","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2174\/18715281113129990054","article-title":"Cardiac involvement in ANCA (+) and ANCA (\u2212) Churg-Strauss syndrome evaluated by cardiovascular magnetic resonance","volume":"12","author":"Mavrogeni","year":"2013","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1016\/j.autrev.2017.12.001_bb0890","first-page":"S41","article-title":"ANCA-positive and ANCA-negative phenotypes of eosinophilic granulomatosis with polyangiitis (EGPA): outcome and long-term follow-up of 50 patients from a single polish center","volume":"32","author":"Sokolowska","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0895","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.autrev.2015.04.013","article-title":"Impact of cardiac magnetic resonance imaging on eosinophilic granulomatosis with polyangiitis outcomes: a long-term retrospective study on 42 patients","volume":"14","author":"Dunogue","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2017.12.001_bb0900","article-title":"T1 and T2 mapping for evaluation of myocardial involvement in patients with ANCA-associated vasculitides","volume":"19","author":"Greulich","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.autrev.2017.12.001_bb0905","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2174\/1871528113666140924123717","article-title":"Cardiovascular magnetic resonance for evaluation of heart involvement in ANCA-associated vasculitis. A luxury or a valuable diagnostic tool?","volume":"13","author":"Mavrogeni","year":"2014","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1016\/j.autrev.2017.12.001_bb0910","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/jep.12709","article-title":"Management of cardiovascular risk factors in patients with ANCA-associated vasculitis","volume":"23","author":"Bramlage","year":"2017","journal-title":"J Eval Clin Pract"},{"key":"10.1016\/j.autrev.2017.12.001_bb0915","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1445-5994.2006.01061.x","article-title":"Cardiac involvement in Henoch-Schonlein purpura","volume":"36","author":"Polizzotto","year":"2006","journal-title":"Intern Med J"},{"key":"10.1016\/j.autrev.2017.12.001_bb0920","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0272-6386(00)70344-1","article-title":"Cardiopulmonary manifestations of Henoch-Schonlein purpura","volume":"35","author":"Agraharkar","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.autrev.2017.12.001_bb0925","doi-asserted-by":"crossref","first-page":"E69","DOI":"10.1161\/01.CIR.101.5.e69","article-title":"Cardiac vasculitis in Henoch-Schonlein purpura","volume":"101","author":"Osman","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2017.12.001_bb0930","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1053\/ajkd.2000.8300","article-title":"Henoch-Schonlein purpura and myocardial necrosis","volume":"36","author":"Robson","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.autrev.2017.12.001_bb0935","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00431-006-0273-2","article-title":"Cardiac manifestations of Henoch-Schoenlein purpura: IgA mediated vasculitis or rheumatic fever?","volume":"166","author":"Shin","year":"2007","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.autrev.2017.12.001_bb0940","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1053\/j.ajkd.2009.04.017","article-title":"Henoch-Schonlein purpura complicated by cardiac involvement: case report and review of the literature","volume":"54","author":"Lutz","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.autrev.2017.12.001_bb0945","doi-asserted-by":"crossref","first-page":"70","DOI":"10.5582\/irdr.2015.01007","article-title":"Cardiac manifestations in Behcet's disease","volume":"4","author":"Demirelli","year":"2015","journal-title":"Intractable Rare Dis Res"},{"key":"10.1016\/j.autrev.2017.12.001_bb0950","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00005792-200301000-00006","article-title":"The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center","volume":"82","author":"Kural-Seyahi","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2017.12.001_bb0955","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/art.27568","article-title":"Mortality in Behcet's disease","volume":"62","author":"Saadoun","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.12.001_bb0960","first-page":"S138","article-title":"Mortality in Behcet's syndrome","volume":"26","author":"Yazici","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0965","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1191\/0961203305lu2208oa","article-title":"Behcet's disease and cardiovascular involvement","volume":"14","author":"Atzeni","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.12.001_bb0970","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/MD.0b013e3182428f49","article-title":"Spectrum of cardiac lesions in Behcet disease: a series of 52 patients and review of the literature","volume":"91","author":"Geri","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2017.12.001_bb0975","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1540-8191.2008.00607.x","article-title":"Cardiac and great vessel involvement in \u201cBehcet's disease\u201d","volume":"23","author":"Marzban","year":"2008","journal-title":"J Card Surg"},{"key":"10.1016\/j.autrev.2017.12.001_bb0980","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s10067-013-2205-7","article-title":"Major vascular involvement in Behcet's disease: a retrospective study of 796 patients","volume":"32","author":"Fei","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0985","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10067-009-1302-0","article-title":"Cardiovascular involvement in Behcet's disease","volume":"29","author":"Sezen","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb0990","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/echo.12659","article-title":"Importance of echocardiographic findings in the acute presentation of Behcet's disease\u2013diagnostic and prognostic considerations","volume":"31","author":"Abidov","year":"2014","journal-title":"Echocardiography"},{"key":"10.1016\/j.autrev.2017.12.001_bb0995","first-page":"S87","article-title":"A rare but serious manifestation of Behcet's disease: intracardiac thrombus in 22 patients","volume":"32","author":"Emmungil","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb1000","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4081\/reumatismo.2016.887","article-title":"Intracardiac thrombus in Behcet's disease","volume":"68","author":"Ben Ghorbel","year":"2016","journal-title":"Reumatismo"},{"key":"10.1016\/j.autrev.2017.12.001_bb1005","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0167-5273(98)00322-2","article-title":"Increased QT dispersion in the absence of QT prolongation in patients with Behcet's disease and ventricular arrhythmias","volume":"67","author":"Aytemir","year":"1998","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2017.12.001_bb1010","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/MCA.0b013e328361a978","article-title":"Assessment of QRS duration and presence of fragmented QRS in patients with Behcet's disease","volume":"24","author":"Sayin","year":"2013","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.autrev.2017.12.001_bb1015","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/ard.55.7.450","article-title":"Cardiac manifestations in primary Sjogren's syndrome","volume":"55","author":"Gyongyosi","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.12.001_bb1020","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/joim.12346","article-title":"Cardiovascular disease risk burden in primary Sjogren's syndrome: results of a population-based multicentre cohort study","volume":"278","author":"Bartoloni","year":"2015","journal-title":"J Intern Med"},{"key":"10.1016\/j.autrev.2017.12.001_bb1025","first-page":"124","article-title":"Primary Sjogren's syndrome and the risk of acute myocardial infarction: a nationwide study","volume":"29","author":"Chiang","year":"2013","journal-title":"Acta Cardiol Sin"},{"key":"10.1016\/j.autrev.2017.12.001_bb1030","first-page":"109","article-title":"Is the heart affected in primary Sjogren's syndrome? An echocardiographic study","volume":"26","author":"Vassiliou","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb1035","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/1756-185X.12049","article-title":"Assessment of left ventricular functions in patients with Sjogren's syndrome using tissue Doppler echocardiography","volume":"16","author":"Bayram","year":"2013","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2017.12.001_bb1040","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1055\/s-0034-1371529","article-title":"Pulmonary involvement in Sjogren syndrome","volume":"35","author":"Kreider","year":"2014","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2017.12.001_bb1045","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ijcard.2017.01.097","article-title":"Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: a cohort study in China","volume":"236","author":"Zhao","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2017.12.001_bb1050","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/1756-185X.12616","article-title":"Cardiac arrhythmias as the initial manifestation of adult primary Sjogren's syndrome: a case report and literature review","volume":"18","author":"Liang","year":"2015","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2017.12.001_bb1055","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s10067-015-2959-1","article-title":"Axial spondyloarthritis: the heart of the matter","volume":"34","author":"Gensler","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb1060","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.semarthrit.2004.07.010","article-title":"Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis","volume":"34","author":"Peters","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.12.001_bb1065","first-page":"292","article-title":"High prevalence of metabolic syndrome and cardiovascular risk factors in men with ankylosing spondylitis on anti-TNFalpha treatment: correlation with disease activity","volume":"27","author":"Papadakis","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb1070","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1136\/annrheumdis-2015-207688","article-title":"Mortality in ankylosing spondylitis: results from a nationwide population-based study","volume":"75","author":"Exarchou","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.12.001_bb1075","first-page":"S80","article-title":"Mortality in ankylosing spondylitis","volume":"26","author":"Zochling","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb1080","first-page":"S127","article-title":"Mortality in rheumatoid arthritis and ankylosing spondylitis","volume":"27","author":"Zochling","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb1085","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ejim.2011.06.006","article-title":"Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications","volume":"22","author":"El Maghraoui","year":"2011","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.autrev.2017.12.001_bb1090","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4250\/jcu.2012.20.1.30","article-title":"Early cardiac valvular changes in ankylosing spondylitis: a transesophageal echocardiography study","volume":"20","author":"Park","year":"2012","journal-title":"J Cardiovasc Ultrasound"},{"key":"10.1016\/j.autrev.2017.12.001_bb1095","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.amjmed.2015.04.032","article-title":"Aortic regurgitation is common in ankylosing spondylitis: time for routine echocardiography evaluation?","volume":"128","author":"Klingberg","year":"2015","journal-title":"Am J Med"},{"issue":"237","key":"10.1016\/j.autrev.2017.12.001_bb1100","article-title":"Cardiac conduction system abnormalities in ankylosing spondylitis: a cross-sectional study","volume":"14","author":"Forsblad-d'Elia","year":"2013","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.autrev.2017.12.001_bb1105","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.semarthrit.2012.04.002","article-title":"Paroxysmal supraventricular tachycardia and Wolff-Parkinson-White syndrome in ankylosing spondylitis: a large cohort observation study and literature review","volume":"42","author":"Ho","year":"2012","journal-title":"Semin Arthritis Rheum"},{"issue":"102","key":"10.1016\/j.autrev.2017.12.001_bb1110","article-title":"Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study","volume":"19","author":"Bengtsson","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.autrev.2017.12.001_bb1115","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.semarthrit.2014.10.007","article-title":"Cardiovascular events in ankylosing spondylitis: an updated meta-analysis","volume":"44","author":"Mathieu","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.12.001_bb1120","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3109\/03009742.2013.822097","article-title":"A nationwide population-based retrospective cohort study: increased risk of acute coronary syndrome in patients with ankylosing spondylitis","volume":"43","author":"Chou","year":"2014","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb1125","article-title":"Increased risk of ischemic heart disease in young patients with newly diagnosed ankylosing spondylitis\u2013a population-based longitudinal follow-up study","volume":"8","author":"Huang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2017.12.001_bb1130","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/annrheumdis-2014-206147","article-title":"Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study","volume":"75","author":"Essers","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.12.001_bb1135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.semarthrit.2014.02.004","article-title":"Diastolic left ventricular dysfunction in ankylosing spondylitis\u2013a systematic review and meta-analysis","volume":"44","author":"Heslinga","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.12.001_bb1140","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/03009742.2014.953201","article-title":"Prevalence of diastolic dysfunction in patients with ankylosing spondylitis: a cross-sectional study","volume":"44","author":"Svealv","year":"2015","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb1145","article-title":"Long-term frequent use of non-steroidal anti-inflammatory drugs might protect patients with ankylosing spondylitis from cardiovascular diseases: a nationwide case-control study","volume":"10","author":"Tsai","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2017.12.001_bb1150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.amjcard.2006.07.069","article-title":"Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials","volume":"99","author":"White","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.autrev.2017.12.001_bb1155","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1136\/annrheumdis-2017-211253","article-title":"Survival benefit of statin use in ankylosing spondylitis: a general population-based cohort study","volume":"76","author":"Oza","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.12.001_bb1160","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijcard.2010.08.013","article-title":"Clinical cardiac involvement in idiopathic inflammatory myopathies: a systematic review","volume":"148","author":"Gupta","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2017.12.001_bb1165","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.3899\/jrheum.130044","article-title":"Left ventricular diastolic dysfunction \u2013 early cardiac impairment in patients with polymyositis\/dermatomyositis: a tissue Doppler imaging study","volume":"40","author":"Lu","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb1170","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1191\/0961203305lu2205oa","article-title":"Cardiac involvement in autoimmune myositis and mixed connective tissue disease","volume":"14","author":"Lundberg","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.12.001_bb1175","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2016-000291","article-title":"Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies","volume":"2","author":"Schwartz","year":"2016","journal-title":"RMD Open"},{"key":"10.1016\/j.autrev.2017.12.001_bb1180","first-page":"686","article-title":"Cardiac involvement in adult polymyositis or dermatomyositis: a systematic review","volume":"35","author":"Zhang","year":"2012","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.autrev.2017.12.001_bb1185","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/ard.2005.038679","article-title":"Effects of corticosteroids and immunosuppressors on idiopathic inflammatory myopathy related myocarditis evaluated by magnetic resonance imaging","volume":"65","author":"Allanore","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.12.001_bb1190","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00415-014-7623-1","article-title":"Early diagnosis of cardiac involvement in idiopathic inflammatory myopathy by cardiac magnetic resonance tomography","volume":"262","author":"Rosenbohm","year":"2015","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2017.12.001_bb1195","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.jcmg.2011.05.009","article-title":"Contrast-enhanced CMR imaging reveals myocardial involvement in idiopathic inflammatory myopathy without cardiac manifestations","volume":"4","author":"Mavrogeni","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.autrev.2017.12.001_bb1200","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2174\/1871528113666140526162640","article-title":"Cardiac and muscular involvement in idiopathic inflammatory myopathies: noninvasive diagnostic assessment and the role of cardiovascular and skeletal magnetic resonance imaging","volume":"13","author":"Mavrogeni","year":"2014","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1016\/j.autrev.2017.12.001_bb1205","doi-asserted-by":"crossref","first-page":"906","DOI":"10.2459\/JCM.0b013e32833cdca8","article-title":"Cardiological features in idiopathic inflammatory myopathies","volume":"11","author":"Bazzani","year":"2010","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.autrev.2017.12.001_bb1210","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/rheumatology\/kel402","article-title":"Heart conduction disorders related to antimalarials toxicity: an analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases","volume":"46","author":"Costedoat-Chalumeau","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2017.12.001_bb1215","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.echo.2004.09.029","article-title":"Chloroquine-induced cardiomyopathy-echocardiographic features","volume":"18","author":"Naqvi","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.autrev.2017.12.001_bb1220","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3109\/08923973.2013.780078","article-title":"Chloroquine cardiomyopathy - a review of the literature","volume":"35","author":"Tonnesmann","year":"2013","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.autrev.2017.12.001_bb1225","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.3899\/jrheum.110959","article-title":"Cardiomyopathy caused by longterm treatment with chloroquine: a rare disease, or a rare diagnosis?","volume":"39","author":"Tonnesmann","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb1230","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/RHU.0000000000000400","article-title":"Hydroxychloroquine-induced cardiomyopathy in systemic lupus erythematosus","volume":"22","author":"Tselios","year":"2016","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.001_bb1235","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2174\/138161212799504759","article-title":"Adverse cardiovascular effects of antirheumatic drugs: implications for clinical practice and research","volume":"18","author":"Gasparyan","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.autrev.2017.12.001_bb1240","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.amjcard.2011.06.054","article-title":"Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease","volume":"108","author":"Micha","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.autrev.2017.12.001_bb1245","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(00)02051-1","article-title":"QT dispersion as a predictor of acute heart failure after high-dose cyclophosphamide","volume":"355","author":"Nakamae","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2017.12.001_bb1250","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/ard.2005.037879","article-title":"A phase I-II trial of autologous peripheral blood stem cell transplantation in the treatment of refractory autoimmune disease","volume":"65","author":"Tsukamoto","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.12.001_bb1255","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/acr.20371","article-title":"Systematic review and meta-analysis: anti-tumor necrosis factor alpha therapy and cardiovascular events in rheumatoid arthritis","volume":"63","author":"Barnabe","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2017.12.001_bb1260","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.autrev.2011.04.014","article-title":"Cardiovascular safety of anti-TNF-alpha therapies: facts and unsettled issues","volume":"10","author":"Cacciapaglia","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.12.001_bb9000","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1191\/0961203305lu2187oa","article-title":"Serositis related to systemic lupus erythematosus: prevalence and outcome","volume":"14","author":"Man","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.12.001_bb9100","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1177\/0961203308100659","article-title":"The spectrum of clinical manifestations, outcome and treatment of pericardial tamponade in patients with systemic lupus erythematosus: a retrospective study and literature review","volume":"18","author":"Rosenbaum","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.12.001_bb9200","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.amjms.2017.01.010","article-title":"Aortic aneurysm in Takayasu arteritis","volume":"353","author":"Yang","year":"2017","journal-title":"Am J Med Sci"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218300041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218300041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T05:09:49Z","timestamp":1751260189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997218300041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":255,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1568997218300041"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2017.12.001","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular involvement in systemic rheumatic diseases: An integrated view for the treating physicians","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2017.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}